Maxime Thoreau

Ferroptosis: molecular mechanisms and health implications

Elements of cancer immunity and the cancer–immune set point

Macrophages in immunoregulation and therapeutics

The molecular machinery of regulated cell death

Delivery technologies for cancer immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Targeting macrophages in cancer immunotherapy

Broadening horizons: the role of ferroptosis in cancer

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Macrophages as regulators of tumour immunity and immunotherapy

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Interferons α and β in cancer: therapeutic opportunities from new insights

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

Selective reactivation of STING signaling to target Merkel cell carcinoma

Copper induces cell death by targeting lipoylated TCA cycle proteins

Therapeutic cancer vaccines

Entosis: The emerging face of non-cell-autonomous type IV programmed death

Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression